Giant Prepyloric Ulcer Haemorrhage: Patient Characteristics, Treatment, and Outcome in 2003–2012

Table 2

Treatment methods and outcome for giant peptic ulcer haemorrhage: group I: giant prepyloric ulcer haemorrhage; group II: giant gastric ulcer haemorrhage; group III: giant duodenal ulcer haemorrhage.

Patients (𝑛)	Group I 𝑛 (%); 24	Group II 𝑛 (%); 115	Group III 𝑛 (%); 92
Treatment methods
Endoscopic treatment in Forrest I-II cases	15/17 (88.2)	76/94 (80.9)	58/70 (82.9)
Repeat endoscopic treatment	3/15 (20.0)	9/76 (11.8)	17/58 (29.3)
Surgical treatment	3 (12.5)^+	14 (12.2)	40 (43.5)
Outcome
Postoperative mortality	0	1/14 (7.1)	3/40 (7.5)
Mortality (total)	0	4 (3.5)	5 (5.4)

Forrest I-II = I: spurting bleeding or oozing bleeding; II: visible vessel or adherent clot; +significant difference between group I and group III.